Literature DB >> 29858812

HLA Typing from Short-Read Sequencing Data with OptiType.

András Szolek1.   

Abstract

The established standards for HLA genotyping rely on targeted DNA sequencing techniques. However, the increasing abundance of short-read sequencing data has prompted a demand for computational tools capable of HLA typing from general purpose sequencing data as well. OptiType is a software that performs HLA typing from short-read DNA and RNA sequencing data, and this chapter guides the user through its installation and usage.

Keywords:  Bioinformatics; HLA class I typing; In silico; Mapping; OptiType; RNA-Seq; Whole-exome Seq

Mesh:

Substances:

Year:  2018        PMID: 29858812     DOI: 10.1007/978-1-4939-8546-3_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.

Authors:  Zexian Zeng; Jingxin Fu; Carrie Cibulskis; Aashna Jhaveri; Curtis Gumbs; Biswajit Das; Beatriz Sanchez-Espiridion; Sylvie Janssens; Daoud Meerzaman; Magdalena Thurin; Andrew Futreal; Chris Karlovich; Stacey B Gabriel; Ignacio Ivan Wistuba; X Shirley Liu; Catherine J Wu; Len Taing; Jin Wang; James Lindsay; Tomas Vilimas; Jianhua Zhang; Collin Tokheim; Avinash Sahu; Peng Jiang; Chunhua Yan; Dzifa Yawa Duose; Ethan Cerami; Li Chen; David Cohen; Qingrong Chen; Rebecca Enos; Xin Huang; Jack J Lee; Yang Liu; Donna S Neuberg; Cu Nguyen; Candace Patterson; Sharmistha Sarkar; Sachet Shukla; Ming Tang; Junko Tsuji; Mohamed Uduman; Xiaoman Wang; Jason L Weirather; Jijun Yu; Joyce Yu; Jianjun Zhang; Jiexin Zhang
Journal:  Clin Cancer Res       Date:  2020-12-15       Impact factor: 12.531

Review 2.  Detecting pathogenic variants in autoimmune diseases using high-throughput sequencing.

Authors:  Matt A Field
Journal:  Immunol Cell Biol       Date:  2020-07-27       Impact factor: 5.126

3.  Comprehensive Genomic Profiling of Rare Tumors in China: Routes to Immunotherapy.

Authors:  Shuhang Wang; Yuan Fang; Ning Jiang; Shujun Xing; Qin Li; Rongrong Chen; Xin Yi; Zhiqian Zhang; Ning Li
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.